O ROURKE & COMPANY Inc Cuts Stake in iShares Biotechnology ETF (NASDAQ:IBB)
O ROURKE & COMPANY Inc decreased its stake in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 2.1% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,625 shares of the financial services provider’s stock after selling 142 shares during the period. […]
More Stories
BMO Capital Markets Lowers Ascot Resources (TSE:AOT) Price Target to C$0.75
Ascot Resources (TSE:AOT – Free Report) had its price objective trimmed by BMO Capital Markets from C$1.25 to C$0.75 in...
Trevena (NASDAQ:TRVN) Coverage Initiated by Analysts at StockNews.com
StockNews.com initiated coverage on shares of Trevena (NASDAQ:TRVN – Free Report) in a research report report published on Tuesday. The...
Aclaris Therapeutics (NASDAQ:ACRS) Upgraded by BTIG Research to Buy Rating
BTIG Research upgraded shares of Aclaris Therapeutics (NASDAQ:ACRS – Free Report) from a neutral rating to a buy rating in...
Siemens Aktiengesellschaft (OTCMKTS:SIEGY) Rating Lowered to Neutral at Bank of America
Bank of America cut shares of Siemens Aktiengesellschaft (OTCMKTS:SIEGY – Free Report) from a buy rating to a neutral rating...
Origin Agritech (NASDAQ:SEED) Earns Hold Rating from Analysts at StockNews.com
StockNews.com began coverage on shares of Origin Agritech (NASDAQ:SEED – Free Report) in a research note published on Tuesday. The...
ProAssurance (NYSE:PRA) Lowered to Hold Rating by StockNews.com
StockNews.com downgraded shares of ProAssurance (NYSE:PRA – Free Report) from a buy rating to a hold rating in a research...